Haller C, Meyer M, Scheele T, Koch A, Forssmann W G, Kübler W
Department of Medicine and Institute of Medical Statistics, University of Heidelberg, Germany.
J Intern Med. 1998 Feb;243(2):155-62. doi: 10.1046/j.1365-2796.1998.00260.x.
Intravascular radiocontrast agents induce a pronounced diuresis. The aim of the present study was to investigate the (patho-)physiological mechanisms of the radiocontrast-induced diuresis.
The fractional excretion of sodium, the urinary excretion of the renal natriuretic peptide urodilatin and the plasma concentration of atrial natriuretic peptide were measured in 42 unselected patients immediately before and after intravascular radiocontrast administration during coronary angiography.
Cardiac catheterization laboratory of a university hospital.
After angiography both the plasma concentration of atrial natriuretic peptide (median post-pre difference: 3.9 pmol L(-1), quartiles -1.2; 7.0) and the urinary excretion of urodilatin (median post-pre difference: 67.0 nmol urodilatin/mol creatinine, quartiles 39.7; 152.1) were increased. The urinary urodilatin excretion was correlated with an increase in the fractional excretion of sodium (median post-pre difference: 1.7%, quartiles 0.6; 3.1). There was no correlation between the serum concentration of atrial natriuretic peptide and urinary sodium excretion. For the radiocontrast-induced increase in both urodilatin and sodium excretion there was no indication for differences between patients without (31) and with (11) intravenous saline infusion.
The radiocontrast-induced diuresis is a natriuresis which is associated with an increased urinary excretion of urodilatin. The association between natriuresis and urinary urodilatin excretion irrespective of baseline volume status corroborates the hypothesis that urodilatin contributes to the sodium excretion after radiocontrast administration in a paracrine manner. This finding has pathophysiological and potentially therapeutic implications in radiocontrast-induced nephropathy.
血管内放射性造影剂可引起显著的利尿作用。本研究旨在探讨放射性造影剂诱导利尿的(病理)生理机制。
在42例未经挑选的患者进行冠状动脉造影期间,于血管内注射放射性造影剂之前及之后立即测量钠的分数排泄、肾利钠肽尿舒张素的尿排泄量以及心房利钠肽的血浆浓度。
一所大学医院的心导管实验室。
血管造影术后,心房利钠肽的血浆浓度(中位数术后-术前差值:3.9 pmol/L,四分位数间距-1.2;7.0)和尿舒张素的尿排泄量(中位数术后-术前差值:67.0 nmol尿舒张素/摩尔肌酐,四分位数间距39.7;152.1)均增加。尿舒张素排泄与钠的分数排泄增加相关(中位数术后-术前差值:1.7%,四分位数间距0.6;3.1)。心房利钠肽的血清浓度与尿钠排泄之间无相关性。对于放射性造影剂诱导的尿舒张素和钠排泄增加,未输注(31例)和输注(11例)静脉生理盐水的患者之间未显示出差异。
放射性造影剂诱导的利尿是一种利钠作用,与尿舒张素的尿排泄增加有关。无论基线容量状态如何,利钠作用与尿舒张素排泄之间的关联证实了尿舒张素以旁分泌方式促进放射性造影剂给药后钠排泄的假说。这一发现对放射性造影剂诱导的肾病具有病理生理及潜在的治疗意义。